Cargando…

Targeting Brain Metastases in Patients with Melanoma

Patients with brain metastases from malignant melanoma historically have a very poor outcome. Surgery and radiotherapy can be used, but for the majority of patients the disease will progress quickly. In the recent past, patients with brain metastases derived only minimal benefit from cytotoxic chemo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papadatos-Pastos, Dionysis, Soultati, Aspasia, Harries, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884779/ https://www.ncbi.nlm.nih.gov/pubmed/24455677 http://dx.doi.org/10.1155/2013/186563

Ejemplares similares

Target-based therapeutic matching of phase I trials in patients with metastatic breast cancer in a tertiary referral centre
por: O’Carrigan, Brent, et al.
Publicado: (2018)

Melanoma Brain Metastases in the Era of Target Therapies: An Overview
por: Becco, Paolo, et al.
Publicado: (2020)

Management of Melanoma Brain Metastases in the Era of Targeted Therapy
por: Shapiro, Daniela Gonsalves, et al.
Publicado: (2011)

Targeted Therapies for Melanoma Brain Metastases
por: Berghoff, Anna S., et al.
Publicado: (2017)

Novel Approaches for Concurrent Irradiation in Locally Advanced Cervical Cancer: Platinum Combinations, Non-Platinum-Containing Regimens, and Molecular Targeted Agents
por: Mountzios, Giannis, et al.
Publicado: (2013)

Clinical implementation of pre-treatment DPYD genotyping in capecitabine-treated metastatic breast cancer patients
por: Stavraka, Chara, et al.
Publicado: (2019)

Combining targeted therapeutics in the era of precision medicine
por: Papadatos-Pastos, D, et al.
Publicado: (2015)

Current Treatment of Melanoma Brain Metastases
por: Nowacka, Agnieszka, et al.
Publicado: (2023)

Immunomodulatory Drugs in Melanoma Brain Metastases
por: Fernandes, Gil Nuno Castro
Publicado: (2019)

How I treat brain metastases of melanoma
por: Eroglu, Z., et al.
Publicado: (2022)

Global incidence and outcome of testicular cancer
por: Shanmugalingam, Thurkaa, et al.
Publicado: (2013)

Triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases
por: Rutkowski, Piotr, et al.
Publicado: (2023)

Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy
por: Rieth, John M., et al.
Publicado: (2021)

Radiation Therapy for Melanoma Brain Metastases: A Systematic Review
por: Thompson, John F., et al.
Publicado: (2022)

Outcomes of Treatment for Melanoma Brain Metastases
por: Janavicius, Mantas, et al.
Publicado: (2020)

Immunotherapy as a Turning Point in the Treatment of Melanoma Brain Metastases
por: Fernandes, Gil Nuno Castro
Publicado: (2023)

Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases
por: In, Gino K., et al.
Publicado: (2020)

Oncolytic Virotherapy for Melanoma Brain Metastases, a Potential New Treatment Paradigm?
por: Soldozy, Sauson, et al.
Publicado: (2021)

Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations—Chances and Challenges
por: Kuske, Marvin, et al.
Publicado: (2018)

The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic review
por: van Opijnen, Mark P., et al.
Publicado: (2019)

Melanoma brain metastases: review of histopathological features and immune-molecular aspects
por: Salvati, Lorenzo, et al.
Publicado: (2020)

Decoding molecular programs in melanoma brain metastases
por: Radke, Josefine, et al.
Publicado: (2022)

Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases
por: Trembath, Dimitri G., et al.
Publicado: (2021)

Current management of melanoma patients with nodal metastases
por: Han, Dale, et al.
Publicado: (2021)

Leptomeningeal Disease (LMD) in Patients with Melanoma Metastases
por: Khaled, Mariam Lotfy, et al.
Publicado: (2023)

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
por: Schaule, Jana, et al.
Publicado: (2020)

Ipilimumab and radiation therapy for melanoma brain metastases
por: Silk, Ann W, et al.
Publicado: (2013)

Determinants of survival in patients with brain metastases from cutaneous melanoma
por: Staudt, M, et al.
Publicado: (2010)

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases
por: Queirolo, Paola, et al.
Publicado: (2014)

Metastatic melanoma: prognostic factors and survival in patients with brain metastases
por: Frinton, E., et al.
Publicado: (2017)

Melanoma Brain Metastases: A Systematic Review of Opportunities for Earlier Detection, Diagnosis, and Treatment
por: Diaz, Michael Joseph, et al.
Publicado: (2023)

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
por: Schaule, Jana, et al.
Publicado: (2020)

Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab
por: Du Four, Stephanie, et al.
Publicado: (2018)

A Contemporary Report of Clinical Outcomes in Patients with Melanoma Brain Metastases
por: Phillips, William J., et al.
Publicado: (2021)

Prognostic Value of Preoperative Inflammatory Markers in Melanoma Patients with Brain Metastases
por: Schneider, Matthias, et al.
Publicado: (2021)

Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases
por: Niessner, Heike, et al.
Publicado: (2013)

Efficacy of immunotherapy for melanoma brain metastases in patients with concurrent corticosteroid exposure
por: Tringale, Kathryn R, et al.
Publicado: (2023)

BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy
por: Chowdhary, Mudit, et al.
Publicado: (2016)

SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases
por: Khan, Muhammad, et al.
Publicado: (2018)

Burden and Risk Factors of Brain Metastases in Melanoma: A Systematic Literature Review
por: Tan, Xiang-Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lv7shk8evjol9h3n2pgk369icp